These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2139938)

  • 1. [Bactericidal activity of imipenem].
    Thabaut A; Meyran M
    Presse Med; 1990 Apr; 19(13):592-7. PubMed ID: 2139938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
    Vurma-Rapp U; Kayser FH; Barberis-Maino L
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():27-33. PubMed ID: 3102452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
    Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
    Weinstein RA; Nathan C; Delzell D; Kabins SA
    Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus].
    Vallée E; Joly-Guillou ML; Bergogne-Berezin E
    Presse Med; 1990 Apr; 19(13):588-91. PubMed ID: 2139937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro bactericidal effect of a beta-lactam+aminoglycoside combination against multiresistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Roussel-Delvallez M; Wallet F; Delpierre F; Courcol RJ
    J Chemother; 1996 Oct; 8(5):365-8. PubMed ID: 8957716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of cefepime against nosocomial isolates.
    Sofianou D; Tsoulfa S; Kontodimou L; Polydorou F; Malaka E
    J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
    Schröter G; Schrettenbrunner A; Strenzel I
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
    Maugein J; Perrier F; Cony Makhoul P; Fourche J; Darmaillac V
    Pathol Biol (Paris); 1995 Apr; 43(4):253-7. PubMed ID: 7567110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
    Kazmierczak A; Siebor E; Acar JF; Denis F; Drugeon H; Fleurette J; Sirot J; Soussy CJ; Thabaut A
    Pathol Biol (Paris); 1991 May; 39(5):384-90. PubMed ID: 1909015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of cefpirome compared with that of other agents.
    Raizes EG; Cantey JR
    J Antimicrob Chemother; 1988 Feb; 21(2):177-81. PubMed ID: 3129388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Lerner SA; Dudek EJ; Boisvert WE; Berndt KD
    Rev Infect Dis; 1984; 6 Suppl 3():S678-88. PubMed ID: 6443769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
    Philippon A
    Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
    Aldridge KE; Henderberg A; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
    J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa.
    Livermore DM; Warner M; Mushtaq S
    J Antimicrob Chemother; 2013 Oct; 68(10):2286-90. PubMed ID: 23696619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
    Digranes A; Dibb WL; Benonisen E; Salveson A
    Chemotherapy; 1985; 31(4):279-85. PubMed ID: 3928281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro emergence of beta-lactam-resistant variants of Pseudomonas aeruginosa.
    Eng RH; Smith SM; Cherubin CE
    J Antimicrob Chemother; 1986 Jun; 17(6):717-23. PubMed ID: 3090007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.